» Authors » Julian Ramirez-Bello

Julian Ramirez-Bello

Explore the profile of Julian Ramirez-Bello including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 80
Citations 488
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Briceno I, Ramirez-Bello J, Montufar-Robles I, Barbosa-Cobos R, Angulo-Ramirez A, Valencia-Pacheco G
J Clin Rheumatol . 2024 Sep; 30(7):283-290. PMID: 39271190
Introduction: Interferon regulatory factor 5 ( IRF5 ) is one of the pivotal genes implicated in systemic lupus erythematosus (SLE) among diverse ethnic groups, including Europeans, Asians, Hispanics, and Africans....
2.
Vargas-Alarcon G, Perez-Mendez O, Martinez-Rios M, Diaz-Santillan I, Morales-Villamil L, Delgadillo-Rodriguez H, et al.
Acta Cardiol . 2024 Jul; 79(6):730-736. PMID: 38973431
Background: In the present study, we evaluated whether gene polymorphisms are associated with the presence of coronary artery disease (CAD). Methods: Two rs11362 , and rs1800972 gene polymorphisms of gene...
3.
Cadena-Sandoval D, Montufar-Robles I, Barbosa-Cobos R, Hernandez-Molina G, Karen Salas-Garcia A, Sanchez-Zauco N, et al.
Arch Rheumatol . 2024 May; 39(1):60-70. PMID: 38774701
Objectives: The aim of our study was to investigate whether TNFAIP3, PTPN22, and TRAF1-5 single nucleotide polymorphisms (SNPs) are associated with susceptibility, severity, or serological markers in primary Sjögren's syndrome...
4.
Cruz-Miranda G, Olarte-Carrillo I, Barcenas-Lopez D, Martinez-Tovar A, Ramirez-Bello J, Ramos-Penafiel C, et al.
Int J Mol Sci . 2024 Feb; 25(3). PMID: 38339034
Acute lymphoblastic leukemia (ALL) represents around 25% of adult acute leukemias. Despite the increasing improvement in the survival rate of ALL patients during the last decade, the heterogeneous clinical and...
5.
Fragoso J, Vargas-Alarcon G, Martinez-Flores A, Montufar-Robles I, Barbosa-Cobos R, Rojas-Velasco G, et al.
Biomol Biomed . 2024 Jan; 24(3):665-672. PMID: 38226800
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for causing coronavirus disease 2019 (COVID-19). The development and severity of this infectious disease is influenced by a combination of environmental...
6.
Montufar-Robles I, Barbosa-Cobos R, Romero-Diaz J, Valencia-Pacheco G, Cabello-Gutierrez C, Ramirez-Bello J
Hum Immunol . 2023 Dec; 85(1):110736. PMID: 38042682
TNFAIP3 is a classical systemic lupus erythematosus (SLE)-associated risk locus identified by genome-wide association studies (GWASs) and replicated by candidate gene association studies primarily in Caucasians and Asians. However, in...
7.
Posadas-Sanchez R, Lopez-Uribe A, Reyes-Barrera J, Ramirez-Bello J, Martinez-Alvarado M, Vargas-Alarcon G
Biomol Biomed . 2023 Oct; 24(2):315-322. PMID: 37838929
Interleukin 6 (IL-6) is a cytokine implicated in the development of atherosclerosis. This study aimed to determine the association of three IL-6 gene polymorphisms with increased carotid intima-media thickness (CIMT)...
8.
Amezcua-Guerra L, Guzman-Martin C, Montufar-Robles I, Springall R, Hernandez-DiazCouder A, Barbosa-Cobos R, et al.
Microorganisms . 2023 Aug; 11(8). PMID: 37630479
Background: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical manifestations of COVID-19 range from mild flu-like symptoms to severe respiratory failure. Nowadays,...
9.
Jimenez-Morales S, Perez-Amado C, Montufar-Robles I, Fragoso J, Aranda-Uribe I, Ramos-Puga D, et al.
Cir Cir . 2023 Apr; 91(2):268-276. PMID: 37084305
Coronavirus (CoV) infections cause respiratory and enteric diseases with clinical manifestations ranging from faint to severe, even lead to death of patients. High connectivity between nations and infectivity of severe...
10.
Mendiola-Soto D, Barcenas-Lopez D, Perez-Amado C, Cruz-Miranda G, Mejia-Arangure J, Ramirez-Bello J, et al.
Int J Mol Sci . 2023 Mar; 24(6). PMID: 36982511
Acute lymphoblastic leukemia (ALL) is the most common kind of pediatric cancer. Although the cure rates in ALL have significantly increased in developed countries, still 15-20% of patients relapse, with...